Detalles de la búsqueda
1.
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
Eur J Haematol
; 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661269
2.
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020.
Br J Haematol
; 201(1): 64-74, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36513500
3.
Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatment.
Eur J Haematol
; 105(2): 156-163, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32248578
4.
Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation.
Oxid Med Cell Longev
; 2021: 8026941, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603952
5.
Peroxiredoxin 6 Serum Levels and Risk of Neutropenic Infections in Diffuse Large B-cell Lymphoma.
Anticancer Res
; 39(9): 4925-4931, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31519597
6.
Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.
J Clin Pathol
; 72(4): 316-321, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30755497
7.
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria.
Hemasphere
; 7(10): e954, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693119
Resultados
1 -
7
de 7
1
Próxima >
>>